Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session 2

3773 - Impact of centralisation of national cancer services on patient outcomes for hepatobiliary cancers in Ireland 2000 – 2016


29 Sep 2019


Poster Display session 2


Tumour Site

Hepatobiliary Cancers


David O Reilly


Annals of Oncology (2019) 30 (suppl_5): v253-v324. 10.1093/annonc/mdz247


D.E. O Reilly1, S. Deady2, P. Walsh2, M. Lowery3

Author affiliations

  • 1 Medical Oncology, St James's Hospital, D08 NHY1 - Dublin/IE
  • 2 Cancer Statistics, National Cancer Registry of Ireland, Cork/IE
  • 3 Medical Oncology, Trinity College Dublin, D08 NHY1 - Dublin/IE


Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 3773


It is internationally recognised that centralisation of specialist cancer services results in improved oncologic outcomes, particularly for rare cancers. Ireland’s oncology services were formally centralised into 8 high volume cancer centres in 2007. We sought to identify changes in the utilisation of cancer treatment modalities and outcomes for patients with hepatobiliary cancers in Ireland pre and post centralisation.


Following local ethics board approval, anonymised patient data was provided by the National Cancer Registry of Ireland (NCRI) regarding all cases of hepatocellular cancer (HCC), cholangiocarcinoma and gallbladder cancers (ICD10: C22, C23 and C24) diagnosed in Ireland between 2000 – 2016. Data analysis was completed in collaboration with the NCRI.


Data from 5733 patients with cholangiocarcinoma, gallbladder cancer and HCC over 16 years were analysed (Table). Similar rates of resection of all cancers were identified (21% pre 2008 and 24% from 2008 -2016). Overall 5-year survival for all cancers evaluated was significantly higher (non-overlapping CI) from 2008 -2016 - 16.1% (95% CI 14.4-17.8%) compared to pre 2008 - 12.6% (95% CI 11.0-14.4%). Despite similar rates of resection, 5-year survival rates for all resected cancers was significantly improved from 2008 - 2016 - 46.0% (95% CI 41.3-50.6%) vs 35.7% (95% CI 30.7-40.6%) prior to this. The most significant changes in use of treatment modality over the time course studied was the number of patients who received chemotherapy only (9% pre 2008 and 19% 2008 -2016, p < 0.01) and the significant increase in the number of patients who underwent adjuvant treatment (21% pre 2008 versus 42% from 2008 - 2016, p < 0.01).Table:


Cancer Subtypes2000-20072008-2016
Cholangiocarcinoma38% (782)41% (1519)
Hepatocellular Carcinoma17% (346)21% (780)
Gallbladder19% (379)13% (497)
Unspecified Subtype26% (537)24% (893)


The establishment of national cancer centres in Ireland in 2007 was associated with improvement in 5-year survival for patients with hepatobiliary malignancies and with increased utilisation of systemic therapy in the advanced and adjuvant settings.

Clinical trial identification

Editorial acknowledgement

We would like to thank all the team at the National Cancer Registry of Ireland for their hard work collecting the data.

Legal entity responsible for the study

St. James’ Hospital, Dublin.


Has not received any funding.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.